Skip to content

Ezetimibe Triol Impurity

Ezetimibe Triol Impurity

Product Description
CAT No.
ALN-E026037
CAS No.
2363086-22-8
Mol. F.
C33H30F2N2OS
Mol. Wt.
572.6
Stock
Please Inquire
Chemical Name : (5R,6S)-1-(4-Fluorophenyl)-5-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-3-((S)-2-hydroxy-1-phenylethyl)-6-(4-hydroxyphenyl)dihydropyrimidine-2,4(1H,3H)-dione
Smiles : FC1=CC=C(N2C(N([C@@H](C3=CC=CC=C3)CO)C([C@H](CC[C@H](O)C4=CC=C(F)C=C4)[C@H]2C5=CC=C(O)C=C5)=O)=O)C=C1
Inchi : InChI=1S/C24H21ClFNO3/c25-17-5-9-19(10-6-17)27-23(16-3-11-20(28)12-4-16)21(24(27)30)13-14-22(29)15-1-7-18(26)8-2-15/h1-12,21-23,28-29H,13-14H2/t21-,22-,23-/m1/s1

Related substances by HPLC method for the detection and evaluation of impurities in ezetimibe drug material

By Rapeti, Durgababu; Reddy, Gudibanda Chandra Sekhar; Narayanarao, Kapavarapu Maruthi Venkata; Shyamala, Pulipaka; Krishna, Rallabhandi MuralinFrom International Journal of Pharmaceutical Sciences and Research (2021), 12(1), 217-225

Stability-indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe from pharmaceuticals and biological samples

By Kurbanoglu, Sevinc; Esim, Ozgur; Ozkan, Cansel Kose; Savaser, Ayhan; Ozkan, Yalcin; Uslu, Bengi; Ozkan, Sibel A. – From Journal of the Turkish Chemical Society, Section A: Chemistry (2020), 7(3), 865-874

Stability-indicating analytical method development using quality by design approach for simultaneous estimation of ezetimibe and glimepiride

By Shah, U.; Shah, Kunti; Patel, Rupal – From Indian Journal of Pharmaceutical Sciences (2019), 81(2), 273-281

Request For Quotation